FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mary Barnette

Research Profile

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Susan J Tudhope; Tricia K Finney-Hayward; Andrew G Nicholson; Ruth J Mayer; Mary S Barnette; Peter J Barnes; Louise E Donnelly
Different mitogen-activated protein kinase-dependent cytokine responses in cells of the monocyte lineage.
Susan J Smith; Lenora B Cieslinski; Robert Newton; Louise E Donnelly; Peter S Fenwick; Andrew G Nicholson; Peter J Barnes; Mary S Barnette; Mark A Giembycz
Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes.
Tadashi Kohyama; Xiangde Liu; Fu-Qiang Wen; Tetsu Kobayashi; Qiuhong Fang; Shinji Abe; Lenora Cieslinski; Mary S Barnette; Stephen I Rennard
Cytokines modulate cilomilast response in lung fibroblasts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mary Barnette (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Susan J Tudhope; Tricia K Finney-Hayward; Andrew G Nicholson; Ruth J Mayer; Mary S Barnette; Peter J Barnes; Louise E Donnelly
Different mitogen-activated protein kinase-dependent cytokine responses in cells of the monocyte lineage.
The Journal of pharmacology and experimental therapeutics 2008;324(1):306-12.
2004: Susan J Smith; Lenora B Cieslinski; Robert Newton; Louise E Donnelly; Peter S Fenwick; Andrew G Nicholson; Peter J Barnes; Mary S Barnette; Mark A Giembycz
Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes.
Molecular pharmacology 2004;66(6):1679-89.
2004: Tadashi Kohyama; Xiangde Liu; Fu-Qiang Wen; Tetsu Kobayashi; Qiuhong Fang; Shinji Abe; Lenora Cieslinski; Mary S Barnette; Stephen I Rennard
Cytokines modulate cilomilast response in lung fibroblasts.
Clinical immunology (Orlando, Fla.) 2004;111(3):297-302.
2003: Susan J Smith; Steven Brookes-Fazakerley; Louise E Donnelly; Peter J Barnes; Mary S Barnette; Mark A Giembycz
Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells.
American journal of physiology. Lung cellular and molecular physiology 2003;284(2):L279-89.
2002: Tadashi Kohyama; Xiangde Liu; Fu-Qiang Wen; Yun Kui Zhu; Hangjun Wang; Hui Jung Kim; Hajime Takizawa; Lenora B Cieslinski; Mary S Barnette; Stephen I Rennard
PDE4 inhibitors attenuate fibroblast chemotaxis and contraction of native collagen gels.
American journal of respiratory cell and molecular biology 2002;26(6):694-701.
2000: Mary S Barnette; David C Underwood
New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung disease.
Current opinion in pulmonary medicine 2000;6(2):164-9.
1999: C D Manning; M Burman; SB Christensen; Lenora B Cieslinski; David Essayan; M Grous; Theodore J Torphy; Mary S Barnette
Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.
British journal of pharmacology 1999;128(7):1393-8.
1999: TJ Reape; K Rayner; C D Manning; A N Gee; Mary S Barnette; K G Burnand; Pieter Groot
Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques.
The American journal of pathology 1999;154(2):365-74.
1999: Mary S Barnette
Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD).
Progress in drug research. Fortschritte der Arzneimittelforschung. Progrès des recherches pharmaceutiques 1999;53():193-229.
1999: Theodore J Torphy; Mary S Barnette; David C Underwood; Don E Griswold; SB Christensen; R D Murdoch; R B Nieman; C H Compton
Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic.
Pulmonary pharmacology & therapeutics 1999;12(2):131-5.
1998: SB Christensen; A Guider; C J Forster; J G Gleason; P E Bender; J M Karpinski; Walter E DeWolf; Mary S Barnette; David C Underwood; Don E Griswold; Lenora B Cieslinski; M Burman; S Bochnowicz; RR Osborn; C D Manning; M Grous; L M Hillegas; J O Bartus; M Dominic Ryan; Drake S Eggleston; R Curtis Haltiwanger; Theodore J Torphy
1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma.
Journal of medicinal chemistry 1998;41(6):821-35.
1998: Mary S Barnette; SB Christensen; David Essayan; M Grous; U Prabhakar; J A Rush; Anne Kagey-Sobotka; Theodore J Torphy
SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions.
The Journal of pharmacology and experimental therapeutics 1998;284(1):420-6.
1997: Henry M Sarau; J A Rush; James J Foley; ME Brawner; Dulcie B Schmidt; John White; Mary S Barnette
Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function.
The Journal of pharmacology and experimental therapeutics 1997;283(1):411-8.
1996: Mary S Barnette; J O Bartus; M Burman; SB Christensen; Lenora B Cieslinski; K M Esser; U S Prabhakar; J A Rush; Theodore J Torphy
Association of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding.
Biochemical pharmacology 1996;51(7):949-56.
1996: C D Manning; Megan M McLaughlin; George P Livi; Lenora B Cieslinski; Theodore J Torphy; Mary S Barnette
Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
The Journal of pharmacology and experimental therapeutics 1996;276(2):810-8.
1995: Theodore J Torphy; H L Zhou; James J Foley; Henry M Sarau; C D Manning; Mary S Barnette
Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists.
The Journal of biological chemistry 1995;270(40):23598-604.
1995: Mary S Barnette; M Grous; Lenora B Cieslinski; M Burman; SB Christensen; Theodore J Torphy
Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site.
The Journal of pharmacology and experimental therapeutics 1995;273(3):1396-402.
1995: Mary S Barnette; C D Manning; Lenora B Cieslinski; M Burman; SB Christensen; Theodore J Torphy
The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity.
The Journal of pharmacology and experimental therapeutics 1995;273(2):674-9.
1994: Theodore J Torphy; Mary S Barnette; Douglas W P Hay; David C Underwood
Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma.
Environmental health perspectives 1994;102 Suppl 10():79-84.
1994: Mary S Barnette; J Rush; Lisa A Marshall; James J Foley; Dulcie B Schmidt; Henry M Sarau
Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.
Biochemical pharmacology 1994;47(9):1661-7.
1994: M Grous; Mary S Barnette
Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonic smooth muscle.
British journal of pharmacology 1994;111(1):259-63.
1993: Mary S Barnette; C D Manning; W J Price; Frank C Barone
Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
The Journal of pharmacology and experimental therapeutics 1993;264(2):801-12.
1992: Mary S Barnette; M Grous
Characterization of the antigen-induced contraction of colonic smooth muscle from sensitized guinea pigs.
The American journal of physiology 1992;262(1 Pt 1):G144-9.
1992: Mary S Barnette; M Grous; C D Manning; W J Price; A H Nelson; W E Bondinell; Frank C Barone; H S Ormsbee
5-Hydroxytryptamine (5-HT) and SK&F 103829 contract canine lower esophageal sphincter smooth muscle by stimulating 5-HT2 receptors.
Receptor 1992;2(3):155-67.
1991: Mary S Barnette; Frank C Barone; P J Fowler; M Grous; W J Price; H S Ormsbee
Human lower oesophageal sphincter relaxation is associated with raised cyclic nucleotide content.
Gut 1991;32(1):4-9.
1990: M Grous; H Ormsbee; Mary S Barnette
Dimethylphenylpiperazinium (DMPP)-induced relaxation and elevation of cyclic GMP content in canine lower esophageal sphincter (LES).
Biochemical pharmacology 1990;40(8):1757-62.
1990: Mary S Barnette; M Grous; C D Manning; J F Callahan; Frank C Barone
Inhibition of neuronally induced relaxation of canine lower esophageal sphincter by opioid peptides.
European journal of pharmacology 1990;182(2):363-8.
1990: Mary S Barnette; M Grous; Theodore J Torphy; H S Ormsbee
Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxation.
The Journal of pharmacology and experimental therapeutics 1990;252(3):1160-6.
1989: Mary S Barnette; Theodore J Torphy; M Grous; C Fine; H S Ormsbee
Cyclic GMP: a potential mediator of neurally- and drug-induced relaxation of opossum lower esophageal sphincter.
The Journal of pharmacology and experimental therapeutics 1989;249(2):524-8.
1986: C A Miller; Mary S Barnette; H S Ormsbee; Theodore J Torphy
Cyclic nucleotide-dependent protein kinases in the lower esophageal sphincter.
The American journal of physiology 1986;251(6 Pt 1):G794-803.
1986: Theodore J Torphy; C F Fine; M Burman; Mary S Barnette; H S Ormsbee
Lower esophageal sphincter relaxation is associated with increased cyclic nucleotide content.
The American journal of physiology 1986;251(6 Pt 1):G786-93.